ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,537.02
0.51%
US Tech 100
19,635.40
0.80%
Dow Jones
39,308.00
-0.06%
Brent Oil
87.07
0.72%
Bitcoin
59,868.26
-3.48%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Carisma Therapeutics Inc (CARM)

  7. Carisma Therapeutics Inc (CARM) News

CARM

Carisma Therapeutics (CARM)

Carisma Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CARM
DateTimeSourceHeadlineSymbolCompany
07/02/202411:45AMBusiness WireCARMILA : Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L.233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des marchés financiersNASDAQ:CARMCarisma Therapeutics Inc
07/02/202411:45AMBusiness WireCARMILA: Information Concerning the Total Number of Voting Rights and ShareNASDAQ:CARMCarisma Therapeutics Inc
07/01/202412:48PMBusiness WireCarmila : Finalisation de l’acquisition de Galimmo SCANASDAQ:CARMCarisma Therapeutics Inc
07/01/202412:48PMBusiness WireCarmila: Closing of the Acquisition of Galimmo SCANASDAQ:CARMCarisma Therapeutics Inc
07/01/20247:30AMPR Newswire (US)Carisma Therapeutics Announces Changes to its Board of DirectorsNASDAQ:CARMCarisma Therapeutics Inc
07/01/20241:00AMBusiness WireCarmila: Potential Stake Increase in Galimmo SCA to 99.9%NASDAQ:CARMCarisma Therapeutics Inc
07/01/20241:00AMBusiness WireCarmila : Participation dans Galimmo SCA potentiellement portée à 99,9%NASDAQ:CARMCarisma Therapeutics Inc
06/27/20244:30PMPR Newswire (US)Carisma Therapeutics Announces Nomination of First In Vivo CAR-M Development Candidate for Hepatocellular Carcinoma Under Collaboration with ModernaNASDAQ:CARMCarisma Therapeutics Inc
06/25/20247:30AMPR Newswire (US)Carisma Therapeutics Granted FDA Fast Track Designation for CT-0525 for the Treatment of HER2-overexpressing Solid TumorsNASDAQ:CARMCarisma Therapeutics Inc
06/25/20247:30AMPR Newswire (US)Carisma Therapeutics to Participate in the Stifel 2024 Cell Therapy ForumNASDAQ:CARMCarisma Therapeutics Inc
06/18/20247:06PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CARMCarisma Therapeutics Inc
06/14/20244:32PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CARMCarisma Therapeutics Inc
06/14/20244:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CARMCarisma Therapeutics Inc
06/13/20244:30PMPR Newswire (US)Carisma Therapeutics Announces Adjournment of Annual Meeting of StockholdersNASDAQ:CARMCarisma Therapeutics Inc
06/05/202411:45AMBusiness WireCARMILA : Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L.233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des marchés financiersNASDAQ:CARMCarisma Therapeutics Inc
06/05/202411:45AMBusiness WireCARMILA: Information Concerning the Total Number of Voting Rights and ShareNASDAQ:CARMCarisma Therapeutics Inc
05/30/20247:30AMPR Newswire (US)Carisma Therapeutics to Participate in the Jefferies Global Healthcare ConferenceNASDAQ:CARMCarisma Therapeutics Inc
05/28/20247:39PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:CARMCarisma Therapeutics Inc
05/16/20247:30AMPR Newswire (US)Carisma Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of CT-0525, a Novel HER2-Targeting CAR-MonocyteNASDAQ:CARMCarisma Therapeutics Inc
05/09/20247:52AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CARMCarisma Therapeutics Inc
05/09/20247:41AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CARMCarisma Therapeutics Inc
05/09/20247:30AMPR Newswire (US)Carisma Therapeutics Reports First Quarter 2024 Financial Results and Recent Business HighlightsNASDAQ:CARMCarisma Therapeutics Inc
05/08/202411:45AMBusiness WireCarmila: Withdrawal of funds for the liquidity contractNASDAQ:CARMCarisma Therapeutics Inc
05/08/202411:45AMBusiness WireCarmila: Réduction des moyens du contrat de liquiditéNASDAQ:CARMCarisma Therapeutics Inc
05/08/20247:30AMPR Newswire (US)Carisma Therapeutics Presents Preclinical Proof of Concept Data Demonstrating the Anti-Fibrotic Potential of Engineered Macrophages at ASGCT 2024NASDAQ:CARMCarisma Therapeutics Inc
05/07/202411:45AMBusiness WireCARMILA : Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L.233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des marchés financiersNASDAQ:CARMCarisma Therapeutics Inc
05/07/202411:45AMBusiness WireCARMILA: Information Concerning the Total Number of Voting Rights and ShareNASDAQ:CARMCarisma Therapeutics Inc
05/06/20247:30AMPR Newswire (US)Carisma Therapeutics to Participate in The Citizens JMP Life Sciences ConferenceNASDAQ:CARMCarisma Therapeutics Inc
05/02/20247:30AMPR Newswire (US)Carisma Therapeutics Appoints Dr. Eugene P. Kennedy as Chief Medical OfficerNASDAQ:CARMCarisma Therapeutics Inc
04/24/20245:05PMPR Newswire (US)Carisma Therapeutics Announces Upcoming Presentation at the American Society of Clinical Oncology (ASCO) 2024 Annual MeetingNASDAQ:CARMCarisma Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:CARM

Your Recent History

NASDAQ
TSLA
Tesla
AMEX
OPTT
Ocean Power Technologies
USOTC
KEGS
1812 Brewing (PK)
USOTC
NNAX
New Momentum (PK)
USOTC
UBQU
Ubiquitech Software (PK)
USOTC
NSAV
Net Savings Link (PK)
USOTC
MGON
Megola (PK)
USOTC
VPLM
Voip Pal Com (QB)
NASDAQ
FCEL
FuelCell Energy
USOTC
CNNA
Cann American (CE)
USOTC
MVNT
Movement Industries (PK)
USOTC
SPZI
Spooz (PK)
USOTC
AXXA
Exxe (PK)
USOTC
ENZC
Enzolytics (PK)
USOTC
VXIT
Virexit Technologies (PK)
USOTC
RSPI
RespireRx Pharmaceuticals (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved